Related Experiment Video
Updated: Feb 28, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The Angel in the Marble: Antibiotic Duration in the Neonatal Intensive Care Unit
Joseph B Cantey1, Dalyn B Guinn2
1Department of Pediatrics, Divisions of Neonatology and Immunology & Infectious Diseases, University of Texas Health San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78232, USA.
Insights
Optimizing antimicrobial stewardship in neonatal intensive care units (NICUs) is crucial. This review examines antibiotic treatment durations for infants, identifying knowledge gaps and proposing safer, shorter treatment strategies.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial stewardship is vital for optimizing clinical outcomes in neonatal intensive care units (NICUs).
- Significant knowledge gaps exist regarding the ideal duration of antimicrobial therapy for neonates.
- Current practices require evidence-based guidelines for antibiotic use in this vulnerable population.
Purpose of the Study:
- To review existing evidence on empiric and definitive antibiotic treatment durations for infants.
- To identify clinical scenarios necessitating further research in neonatal antibiotic therapy.
- To propose a goal-based framework for clinical studies investigating shorter antibiotic durations while ensuring infant safety.
Main Methods:
- This study is a narrative review of existing literature.
- It synthesizes evidence on antibiotic treatment durations for neonatal infections.
- It focuses on identifying research gaps and proposing future study designs.
Main Results:
- The review highlights variability in current antibiotic treatment durations for neonatal infections.
- Specific clinical situations requiring further investigation are identified.
- A need for evidence-based, shorter treatment durations is emphasized.
Conclusions:
- Further research is essential to establish optimal, evidence-based antibiotic treatment durations for neonates.
- A rational, goal-based approach to clinical studies is proposed to ensure infant safety during de-escalation of antibiotic therapy.
- Optimizing antimicrobial stewardship through refined treatment durations can improve neonatal outcomes.
Abstract:
Antimicrobial stewardship in the neonatal intensive care unit is a critically important tool to optimize clinical outcomes. The ideal duration of antimicrobial treatment is a key area that contains many knowledge gaps. This narrative review has three aims. One, to highlight the existing evidence for empiric and definitive antibiotic treatment durations for infants; two, to focus on clinical situations where further studies are needed; and three, to propose a rational, goal-based approach to clinical studies that provide for infant safety as shorter treatment durations are investigated.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

